HedgeMountain

MSD Partners, L.P.

New York, NY · CRD 161664
Hedge fund manager

MSD Partners, L.P. is an SEC-registered investment adviser based in New York, NY that reports managing 20 hedge funds on Form ADV. It reports $21.3 billion in regulatory assets under management. Its private funds, of all types, hold $20.4 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated -33.5% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated -32.6% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.

Regulatory assets under management
$21.3 billionForm ADV Item 5.F
Gross assets of private funds
$20.4 billionAll private fund types, Form ADV
Hedge funds managed
2053 private funds in total
Employees
498Form ADV Item 5.A
Registration
SEC-registered adviserCRD 161664
Latest Form ADV
08/24/2026Disciplinary disclosures: none reported

Estimated 13F portfolio performance

Est. 2026 YTD-33.5%Through Q2 2026 · S&P 500 +9.5%
Est. 2-year return-32.6%Q3 2024 – Q2 2026
S&P 500+37.2%Same quarters, price only
13F holdings$76.8 million9 positions, 2026-06-30
$51$107$163Q3 2024Q1 2025Q3 2025Q1 202613F est. $67S&P 500 $137
QuarterEst. 13F returnS&P 500
Q2 2026+33.2%+14.8%
Q1 2026-50.1%-4.6%
Q4 2025-29.0%+2.4%
Q3 2025-12.3%+7.8%
Q2 2025+42.7%+10.4%
Q1 2025-8.5%-4.5%
Q4 2024+2.8%+2.1%
Q3 2024+21.4%+5.4%

Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures

Largest disclosed holdings

  • Oddity Tech LTD$27.0 million
  • Renew Energy Global PLC$13.1 million
  • Xponential Fitness Inc$11.5 million
  • 05501u601$10.3 million
  • Lindblad Expeditions Hldgs I$9.8 million
  • Safehold Inc$3.5 million
  • Servicetitan Inc CL A$1.3 million
  • 67623c307$182,019
  • Trisalus Life Sciences Inc$181,995

As of 2026-06-30, from 13F filing by MSD Partners, L.P..

From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures